In a biological system, nanoparticles (NPs) may interact with biomolecules. Specifically, the adsorption of proteins on the nanoparticle surface may influence both the nanoparticles' and proteins' overall bio-reactivity. Nevertheless, our knowledge of the biocompatibility and risk of exposure to nanomaterials is limited. Here, in vitro and ex ovo biocompatibility of naturally based crosslinked freeze-dried 3D porous collagen/chitosan scaffolds, modified with thermostable fibroblast growth factor 2 (FGF2-STAB®), to enhance healing and selenium nanoparticles (SeNPs) to provide antibacterial activity, were evaluated. Biocompatibility and cytotoxicity were tested in vitro using normal human dermal fibroblasts (NHDF) with scaffolds and SeNPs and FGF2-STAB® solutions. Metabolic activity assays indicated an antagonistic effect of SeNPs and FGF2-STAB® at high concentrations of SeNPs. The half-maximal inhibitory concentration (IC50) of SeNPs for NHDF was 18.9 µg/ml and IC80 was 5.6 µg/ml. The angiogenic properties of the scaffolds were monitored ex ovo using a chick chorioallantoic membrane (CAM) assay and the cytotoxicity of SeNPs over IC80 value was confirmed. Furthermore, the positive effect of FGF2-STAB® at very low concentrations (0.01 µg/ml) on NHDF metabolic activity was observed. Based on detailed in vitro testing, the optimal concentrations of additives in the scaffolds were determined, specifically 1 µg/ml of FGF2-STAB® and 1 µg/ml of SeNPs. The scaffolds were further subjected to antimicrobial tests, where an increase in selenium concentration in the collagen/chitosan scaffolds increased the antibacterial activity. This work highlights the antimicrobial ability and biocompatibility of newly developed crosslinked collagen/chitosan scaffolds involving FGF2-STAB® and SeNPs. Moreover, we suggest that these sponges could be used as scaffolds for growing cells in systems with low mechanical loading in tissue engineering, especially in dermis replacement, where neovascularization is a crucial parameter for successful skin regeneration. Due to their antimicrobial properties, these scaffolds are also highly promising for tissue replacement requiring the prevention of infection.

Biomedical Center Medical Faculty in Pilsen Charles University Alej Svobody 1655 76 323 00 Pilsen Czech Republic

CEITEC Central European Institute of Technology Brno University of Technology Purkynova 656 123 612 00 Brno Czech Republic

Department of Chemistry and Biochemistry Mendel University in Brno Zemedelska 1665 1 613 00 Brno Czech Republic

Department of Inorganic Chemistry Faculty of Science Palacky University 17 Listopadu 12 771 46 Olomouc Czech Republic

Department of Materials Science and Engineering Kroto Research Institute North Campus University of Sheffield Broad Lane Sheffield S3 7HQ UK

Zobrazit více v PubMed

Amani H, et al. Antioxidant nanomaterials in advanced diagnoses and treatments of ischemia reperfusion injuries. J Mater Chem B. 2017;5(48):9452–9476. doi: 10.1039/C7TB01689A. PubMed DOI

Amani H, et al. Selenium nanoparticles for targeted stroke therapy through modulation of inflammatory and metabolic signaling. Sci Reports. 2019;12:9. PubMed PMC

Babrnáková J, Pavliňáková V, Brtníková J, Sedláček P, Prosecká E, Rampichová M, Filová E, Hearnden V, Vojtová V. Synergistic effect of bovine platelet lysate and various polysaccharides on the biological properties of collagen-based scaffolds for tissue engineering: Scaffold preparation, chemo-physical characterization, in vitro and ex ovo evaluation. Mater Sci Eng C. 2019;100:236-46. PubMed

Beheshti N, et al. Efficacy of biogenic selenium nanoparticles against Leishmania major: in vitro and in vivo studies. J Trace Elements Med Biol. 2013;27(3):203–7. doi: 10.1016/j.jtemb.2012.11.002. PubMed DOI

Brown K, Arthur J. Selenium, selenoproteins and human health: a review. Public Health Nutr. 2001;4(2B):593–9. doi: 10.1079/PHN2001143. PubMed DOI

Cihalova K, et al. Staphylococcus aureus and MRSA growth and biofilm formation after treatment with antibiotics and SeNPs. Int J Mol Sci. 2015;16(10):24656–24672. doi: 10.3390/ijms161024656. PubMed DOI PMC

Di Gioacchino M, et al. Immunotoxicity of nanoparticles. Int J Immunopathol Pharmacol. 2011;24(1):65S–71S. PubMed

Dohle DS, et al. Chick ex ovo culture and ex ovo CAM assay: how it really works. J Visualiz Exp. 2010;33:1620. PubMed PMC

Dorazilová J, et al. Synergistic effect of chitosan and selenium nanoparticles on biodegradation and antibacterial properties of collagenous scaffolds designed for infected burn wounds. Nanomaterials. 2020;10(10):1–20. doi: 10.3390/nano10101971. PubMed DOI PMC

Drury JL, Mooney DJ. Hydrogels for tissue engineering: Scaffold design variables and applications. Biomaterials. 2003;24(24):4337–4351. doi: 10.1016/S0142-9612(03)00340-5. PubMed DOI

Geoffrion LD, et al. Naked Selenium Nanoparticles for Antibacterial and Anticancer Treatments. ACS Omega. 2020;5(6):2660–2669. doi: 10.1021/acsomega.9b03172. PubMed DOI PMC

Guisbiers G, et al. Inhibition of Candida albicans biofilm by pure selenium nanoparticles synthesized by pulsed laser ablation in liquids. Nanomedicine. 2017;13(3):1095–1103. doi: 10.1016/j.nano.2016.10.011. PubMed DOI PMC

Hariharan H, Al-Harbi A, Karuppiah P, Kumar Rajaram S. microbial Synthesis of selinium nanocomposite using Saccharomyces cerevisiae and its antimicrobial activity against pathogens causing nosocomial infECTION. Chalcogenide Letters. 2012;9(12):509–515.

Hegerova D, et al. Antimicrobial agent based on selenium nanoparticles and carboxymethyl cellulose for the treatment of bacterial infections. J Biomed Nanotechnol. 2017;13(7):767–777. doi: 10.1166/jbn.2017.2384. DOI

He Y, et al. Toxicity of selenium nanoparticles in male Sprague-Dawley rats at supranutritional and nonlethal levels. Life Sci. 2014;115(1):44–51. doi: 10.1016/j.lfs.2014.08.023. PubMed DOI

Hoffman AS. Hydrogels for biomedical applications. Adv Drug Deliv Rev. 2012;64:18–23. doi: 10.1016/j.addr.2012.09.010. PubMed DOI

Huang X, et al. Investigation of functional selenium nanoparticles as potent antimicrobial agents against superbugs. Acta Biomaterialia. 2016;30:397–407. doi: 10.1016/j.actbio.2015.10.041. PubMed DOI

Chang C, Gershwin ME. Drugs and autoimmunity—a contemporary review and mechanistic approach. J Autoimmun. 2010;34(3):J266–75. doi: 10.1016/j.jaut.2009.11.012. PubMed DOI

Chudobova D, et al. Comparison of the effects of silver phosphate and selenium nanoparticles on Staphylococcus aureus growth reveals potential for selenium particles to prevent infection. FEMS Microbiol Lett. 2014;351:195–201. doi: 10.1111/1574-6968.12353. PubMed DOI

Johnson M. Fetal bovine serum. Mater Methods. 2012;32:117.

Kalishwaralal K, et al. Silver nanoparticles inhibit VEGF induced cell proliferation and migration in bovine retinal endothelial cells. Colloids Surfaces B. 2009;73(1):51–57. doi: 10.1016/j.colsurfb.2009.04.025. PubMed DOI

Khurana A, et al. Therapeutic applications of selenium nanoparticles. Biomed Pharmacother. 2019;111:802–812. doi: 10.1016/j.biopha.2018.12.146. PubMed DOI

Kielczykowska M, Kocot J, Pazdzior M, Musik I. Selenium - a fascinating antioxidant of protective properties. Adv Clin Exp Med. 2018;27(2):245–255. doi: 10.17219/acem/67222. PubMed DOI

Lee AS, et al. Methicillin-resistant Staphylococcus aureus. Nat Rev Dis Prim. 2018;5:4. PubMed

Lee KY, Mooney DJ. Hydrogels for tissue engineering. Chem Rev. 2001;101(7):1869–1879. doi: 10.1021/cr000108x. PubMed DOI

Li X, Xu H, Chen ZS, Chen G. Biosynthesis of nanoparticles by microorganisms and their applications. J Nanomater. 2011;2011:1687–4110.

Loomba L, Scarabelli T. Metallic nanoparticles and their medicinal potential. Part I: Gold and silver colloids. Ther Delivery. 2013;4(7):859–73. doi: 10.4155/tde.13.55. PubMed DOI

MacFarquhar JK, et al. Acute selenium toxicity associated with a dietary supplement. Archiv Intern Med. 2010;170(3):256–61. doi: 10.1001/archinternmed.2009.495. PubMed DOI PMC

Menon S, Shanmugam VK. Chemopreventive mechanism of action by oxidative stress and toxicity induced surface decorated selenium nanoparticles. J Trace Elem Met Biol. 2020;62:126549. doi: 10.1016/j.jtemb.2020.126549. PubMed DOI

Monopoli MP, Åberg C, Salvati A, Dawson KA. Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol. 2012;7(12):779–786. doi: 10.1038/nnano.2012.207. PubMed DOI

Navarro-Alarcon M, Cabrera-Vique C. Selenium in food and the human body: A review. Sci Total Environ. 2008;400(1–3):115–41. doi: 10.1016/j.scitotenv.2008.06.024. PubMed DOI

Pelgrift RY, Friedman AJ. Nanotechnology as a therapeutic tool to combat microbial resistance. Adv Drug Deliv Rev. 2013;65(13–14):1803–15. doi: 10.1016/j.addr.2013.07.011. PubMed DOI

Piętka-Ottlik M, et al. New organoselenium compounds active against pathogenic bacteria. Fungi and Viruses. Chem Pharm Bull. 2008;56(10):1423–7. doi: 10.1248/cpb.56.1423. PubMed DOI

Ramos JF, Tran PA, Webster TJ. Selenium nanoparticles for the prevention of PVC-related medical infections. IEEE. 2012;12:58.

Ratushnaya EV, et al. SYNTHESIS And Antibacterial Activity Of Organoselenium compounds. Pharm Chem J. 2002;36:652–653. doi: 10.1023/A:1023405611793. DOI

Richtera L, et al. The composites of graphene oxide with metal or semimetal nanoparticles and their effect on pathogenic microorganism. Materials. 2015;8(6):2994–3011. doi: 10.3390/ma8062994. DOI

Saptarshi SR, Duschl A, Lopata AL. Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle. J Nanobiotechnol. 2013;7:11. PubMed PMC

Shakibaie M, et al. Anti-biofilm activity of biogenic selenium nanoparticles and selenium dioxide against clinical isolates of Staphylococcus aureus, Pseudomonas aeruginosa, and Proteus mirabilis. J Trace Elements Med Biol. 2015;29:235–241. doi: 10.1016/j.jtemb.2014.07.020. PubMed DOI

Shakibaie M, et al. Acute and subacute toxicity of novel biogenic selenium nanoparticles in mice. Pharm Biol. 2013;51(1):58–63. doi: 10.3109/13880209.2012.710241. PubMed DOI

Skalickova S, et al. Selenium nanoparticles as a nutritional supplement. Nutrition. 2017;33:83–90. doi: 10.1016/j.nut.2016.05.001. PubMed DOI

Sloviková A, Vojtová L, Jančař J. Preparation and modification of collagen-based porous scaffold for tissue engineering. Chem Papers. 2008;62:417–422. doi: 10.2478/s11696-008-0045-8. DOI

Spallholz JE. On the nature of selenium toxicity and carcinostatic activity. Free Radic Biol Med. 1994;17(1):45–64. doi: 10.1016/0891-5849(94)90007-8. PubMed DOI

Tong SYC, et al. Staphylococcus aureus infections: Epidemiology, pathophysiology, clinical manifestations, and management. ClinMicrobiol Rev. 2015;28(3):603–661. PubMed PMC

Tran PA, et al. Low cytotoxic trace element selenium nanoparticles and their differential antimicrobial properties against S. aureus and E. coli. Nanotechnology. 2015;27(4):45101. doi: 10.1088/0957-4484/27/4/045101. PubMed DOI

Tran PA, Webster TJ. Selenium nanoparticles inhibit Staphylococcus aureus growth. Int J Nanomed. 2011;6:1553–8. PubMed PMC

Tran PA, Webster TJ. Antimicrobial selenium nanoparticle coatings on polymeric medical devices. Nanotechnology. 2013;24(15):155101. doi: 10.1088/0957-4484/24/15/155101. PubMed DOI

Verlee A, Mincke S, Stevens CV. Recent developments in antibacterial and antifungal chitosan and its derivatives. Carbohydr Polym. 2017;164:268–283. doi: 10.1016/j.carbpol.2017.02.001. PubMed DOI

Wadhwani SA, Shedbalkar UU, Singh R, Chopade BA. Biogenic selenium nanoparticles: current status and future prospects. Appl Microbiol Biotechnol. 2016;100:2555–2566. doi: 10.1007/s00253-016-7300-7. PubMed DOI

Wang L, Hu C, Shao L. The antimicrobial activity of nanoparticles: Present situation and prospects for the future. Int J Nanomedicine. 2017;12:1227–1249. doi: 10.2147/IJN.S121956. PubMed DOI PMC

Wang Q, Webster TJ. Nanostructured selenium for preventing biofilm formation on polycarbonate medical devices. J Biomed Mater Res. 2012;100(12):3205–3210. doi: 10.1002/jbm.a.34262. PubMed DOI

Wang Q, Webster TJ. Short communication: Inhibiting biofilm formation on paper towels through the use of selenium nanoparticles coatings. Int J Nanomed. 2013;8:407–411. PubMed PMC

Yang J, et al. Antibacterial action of selenium-enriched probiotics against pathogenic Escherichia coli. Digest Dis Sci. 2009;54(2):246–54. doi: 10.1007/s10620-008-0361-4. PubMed DOI

Yan L, Gu Z, Zhao Y. Chemical mechanisms of the toxicological properties of nanomaterials: generation of intracellular reactive oxygen species. Chem Asian J. 2013;8(10):2342–53. doi: 10.1002/asia.201300542. PubMed DOI

Yip J, et al. Investigation of antifungal and antibacterial effects of fabric padded with highly stable selenium nanoparticles. J Appl Polym Sci. 2014;131(17):8886–8893. doi: 10.1002/app.40728. DOI

Zhang J, Wang X, Xu TT. Elemental selenium at nano size (Nano-Se) as a potential chemopreventive agent with reduced risk of selenium toxicity: comparison with se-methylselenocysteine in mice. Toxicol Sci. 2008;101(1):22–31. doi: 10.1093/toxsci/kfm221. PubMed DOI

Zhang L, Pornpattananangkul D, Hu C-M, Huang C-M. Development of Nanoparticles for Antimicrobial Drug Delivery. Curr Med Chem. 2010;17:6. doi: 10.2174/157340610791208763. PubMed DOI

In vivo evaluation of selenium-tellurium based nanoparticles as a novel treatment for bovine mastitis

Accelular nanofibrous bilayer scaffold intrapenetrated with polydopamine network and implemented into a full-thickness wound of a white-pig model affects inflammation and healing process

Lumbar Interbody Fusion Conducted on a Porcine Model with a Bioresorbable Ceramic/Biopolymer Hybrid Implant Enriched with Hyperstable Fibroblast Growth Factor 2

Healing and Angiogenic Properties of Collagen/Chitosan Scaffolds Enriched with Hyperstable FGF2-STAB® Protein: In Vitro, Ex Ovo and In Vivo Comprehensive Evaluation